On 13 June 2024, the new Regulation (EU) 2024/1689 on Artificial Intelligence came into force, establishing a harmonised regulatory framework that redefines the requirements for the development,...
To mark World Alzheimer’s Day (21 September), Basque Health Cluster is joining the Accexible campaign, which runs from 18 September to 2 October 2025..The initiative seeks to raise awareness of the...
Thanks to ACESABIO‘s network collaboration, Basque Health Cluster offers its member companies the Foundernest tool, a powerful market intelligence solution..Foundernest is a market intelligence...
Bilbao, July 29, 2025..Biotech company Mikrobiomik has officially begun patient recruitment for LiverGut, a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial...
Introducing the ELISA Kit ABK1-E6325—a highly sensitive and specific solution designed for the reliable quantification of BSA across a wide range of biological samples, including serum, plasma,...
We are pleased to announce and welcome four new entities joining our community of innovation, collaboration and growth in the field of health this July..We would like to thank ALCAD ELECTRONICS, CT...
The ENS certificate obtained in the audit carried out by AENOR guarantees that NorayBio has the necessary security measures to protect its information systems, data and electronic services. For...
Experts in the sector analyzed in a Side Event the challenges and opportunities offered by a digital, innovative, and interoperable healthcare system for health stakeholders..The Basque Health...
The Basque Health Cluster, together with Basque Trade & Investment / Basque Internationalisation Agency and nine of our partners, will have its own stand at the Medica 2024 fair, which will take...
The Basque Health Cluster family continues to grow, with four new entities becoming BHC partners this October. We would like to give our warmest welcome to Albian Group, Matia Fundazioa, Gureak and...
On the 8th of November, Tuesday, BIOLAN participated in the monitoring meeting of the OSASUN KM0 partnership. During this meeting, the progress of the project and the necessary steps to create and...
[vc_row][vc_column][vc_column_text]Step Oncology, the technological tool developed by the Guipuzkoa-based company (partially funded by the SPRI Group through a Venture Capital Society), has received...
